To what extent are topical tacrolimus or pimecrolimus associated with increased risk of skin cancer and lymphoma? Longterm results from Joelle study

Alejandro Arana,Anton Pottegård,Josephina G. Kuiper,Elizabeth Crellin,Johan Reutfors,Marcus Schmitt-Egenolf,Lars Christian Lund,E. Houben,Helen P Booth,Brian Calingaert,James A. Kaye,Karin Gembert,Kenneth J. Rothman,Daniel Dedman,Helle Kieler,Lia Gutierrez,Jesper Hallas,Susana Perez-Gutthann

To what extent are topical tacrolimus or pimecrolimus associated with increased risk of skin cancer and lymphoma? Longterm results from Joelle study

2020

Alejandro Arana
Anton Pottegård
Josephina G. Kuiper
Elizabeth Crellin
Johan Reutfors
Marcus Schmitt-Egenolf
Lars Christian Lund
E. Houben
Helen P Booth
Brian Calingaert
James A. Kaye
Karin Gembert
Kenneth J. Rothman
Daniel Dedman
Helle Kieler
Lia Gutierrez
Jesper Hallas
Susana Perez-Gutthann

To what extent are topical tacrolimus or pimecrolimus associated with increased risk of skin cancer and lymphoma? : Longterm results from Joelle study

Keywords:

Dermatology
increased risk
Skin cancer
Topical tacrolimus
Pimecrolimus
Lymphoma
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations